Ans van der Ploeg

2.7k citations

49 papers · 1.2k indexed · h-index 13

Co-authors: Arnold Reuser Priya S. Kishnani Michael Beck André Bernards John C. Boothroyd George Cross Sharon L. Coleman Marian A. Kroos
Topics: Lysosomal Storage Disorders Research (44 papers)Glycogen Storage Diseases and Myoclonus (30 papers)Child Nutrition and Feeding Issues (15 papers)
Cited by: Rheumatology Physiology Epidemiology
Journals: Cell Neurology PEDIATRICS
Partner nations: Netherlands United States Germany

In The Last Decade

Ans van der Ploeg

42 papers receiving 1.1k citations

Peers

Countries citing papers authored by Ans van der Ploeg

Since Specialization

Citations

This map shows the geographic impact of Ans van der Ploeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ans van der Ploeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ans van der Ploeg more than expected).

Fields of papers citing papers by Ans van der Ploeg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ans van der Ploeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ans van der Ploeg. The network helps show where Ans van der Ploeg may publish in the future.

Co-authorship network of co-authors of Ans van der Ploeg

This figure shows the co-authorship network connecting the top 25 collaborators of Ans van der Ploeg. A scholar is included among the top collaborators of Ans van der Ploeg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ans van der Ploeg. Ans van der Ploeg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using Out-of-Batch Reference Populations to Improve Untargeted Metabolomics for Screening Inborn Errors of Metabolism 2020 ·Metabolites ·(unknown),(unknown),Serwet Demirdas,Edwin H. Jacobs,Esmée Oussoren,Ans van der Ploeg,Margreet A. E. M. Wagenmakers,Robert M.W. Hofstra,Henk J. Blom,Marcel Reinders,George J. G. Ruijter	12
2	Respiratory function during enzyme replacement therapy in late-onset Pompe disease: longitudinal course, prognostic factors, and the impact of time from diagnosis to treatment start 2020 ·Journal of Neurology ·David W. Stockton,Priya S. Kishnani,Ans van der Ploeg,Juan Clinton Llerena,Matthias Boentert,Mark Roberts,Barry J. Byrne,(unknown),Sonia S. Maruti,Nathan Thibault,(unknown),Kenneth I. Berger	20
3	Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison 2018 ·Genetics in Medicine ·Julie B. Eisengart,Kyle Rudser,Yong Xue,Paul J. Orchard,Weston P. Miller,Troy C. Lund,Ans van der Ploeg,Jean Mercer,Simon Jones,Eugen Mengel,(unknown),Nathalie Guffon,Roberto Giugliani,(unknown),Elsa Shapiro,Chester B. Whitley	43
4	Long-Term Efficacy of Alglucosidase Alfa in Late-Onset Pompe Disease (P1.120) 2017 ·Neurology ·Paula R. Clemens,Pascal Laforêt,Katherine Kacena,Bernd‐Jan Sanson,Robert J. Hopkin,Ans van der Ploeg	1
5	Phase 1 Safety and Pharmacokinetics of the Novel Enzyme Replacement Therapy neoGAA in Treatment-Naïve and Alglucosidase Alfa-Treated Late-Onset Pompe Disease Patients (S38.005) 2016 ·Neurology ·Jaya Trivedi,Ans van der Ploeg,Richard J. Barohn,Barry J. Byrne,Claude Desnuelle,Özlem Göker-Alpan,Shafeeq Ladha,Pascal Laforêt,Eugen Mengel,Alan Pestronk,Jean Pouget,Benedikt Schoser,Volker Straub,Philip Van Damme,John Vissing,Peter Young,Raheel Shafi,Kerry Culm-Merdek,(unknown),(unknown)	1
6	The Pompe Registry: 10 Years of Data 2015 ·Journal of Neuromuscular Diseases ·(unknown),(unknown),Yin‐Hsiu Chien,Juan Clinton Llerena,Judy Kempf,(unknown),Ans van der Ploeg	2
7	Ten Years of The International Pompe Survey: Patient Reported Outcomes As A Reliable Tool for Studying Treated and Untreated Children and Adults With Non-Classic Pompe Disease 2015 ·Value in Health ·(unknown),Deniz Güngör,Michelle E. Kruijshaar,(unknown),Andrew D Muir,Ans van der Ploeg	5
8	A Phase 4 Prospective Study in Patients with Adult Pompe Disease Treated with Alglucosidase Alfa 2015 ·Journal of Neuromuscular Diseases ·Beth L. Thurberg,Pierre G. Carlier,John T. Kissel,Benedikt Schoser,Alan Pestronk,Richard J. Barohn,Özlem Göker-Alpan,Tahseen Mozaffar,Loren Peña,Zachary Simmons,Volker Straub,Peter Young,Raheel Shafi,Carl Bjartmar,Ans van der Ploeg	1
9	Survival and Developmental Milestones Among Pompe Registry Patients with Classic Infantile-Onset Pompe Disease with Different Timing of Initiation of Treatment with Enzyme Replacement Therapy 2015 ·Journal of Neuromuscular Diseases ·Yin‐Hsiu Chien,Ans van der Ploeg,Simon W. Jones,Barry J. Byrne,(unknown),Nancy Leslie,Eugen Mengel,Suma P. Shankar,Pranoot Tanpaiboon,David W. Stockton,Julia B. Hennermann,(unknown),Judy Kempf,Joan Keutzer,Priya S. Kishnani	2
10	Lentiviral Stem Cell Gene Therapy for Pompe Disease 2015 ·Journal of Neuromuscular Diseases ·(unknown),Merel Stok,(unknown),(unknown),(unknown),Dirk J. Duncker,Arnold Reuser,Ans van der Ploeg,Arnold G. Vulto,Niek P. van Til,Gerard Wagemaker	4
11	Macrophage involvement in mitral valve pathology in mucopolysaccharidosis type VI (Maroteaux–lamy syndrome) 2013 ·American Journal of Medical Genetics Part A ·Marion M. Brands,(unknown),Ronald R. de Krijger,Ad J.J.C. Bogers,Arnold Reuser,Ans van der Ploeg,Willem A. Helbing	5
12	A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function 2013 ·BMC Musculoskeletal Disorders ·(unknown),Iris Plug,Marian A. Kroos,Arnold Reuser,Ans van der Ploeg	5
13	Effects of exercise training in 23 adults with Pompe disease receiving enzyme therapy 2013 ·BMC Musculoskeletal Disorders ·Linda van den Berg,Marein M. Favejee,Stephan C.A. Wens,Michelle E. Kruijshaar,Francois Karstens,(unknown),Stephan Praet,Arnold Reuser,W.W.M. Pim Pijnappel,Johannes B. J. Bussmann,P. van Doorn,Harm Kuipers,Ans van der Ploeg	1
14	The genotype–phenotype correlation in Pompe disease 2012 ·American Journal of Medical Genetics Part C Seminars in Medical Genetics ·Marian A. Kroos,Marianne Hoogeveen‐Westerveld,Ans van der Ploeg,Arnold Reuser	93
15	Pompe disease: Design, methodology, and early findings from the Pompe Registry 2011 ·Molecular Genetics and Metabolism ·Barry J. Byrne,Priya S. Kishnani,Laura E. Case,Luciano Merlini,Wolfgang Müller‐Felber,Suyash Prasad,Ans van der Ploeg	115
16	Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease 2009 ·Pediatric Research ·Priya S. Kishnani,Deya Corzo,Nancy D. Leslie,Daniel Gruskin,Ans van der Ploeg,John Clancy,Rossella Parini,Gilles Morin,Michael Beck,Mislen Bauer,(unknown),(unknown),(unknown),Claire Morgan,Tara O’Meara,Susan Richards,Elisa Tsao,Hanna Mandel	232
17	M.P.2.06 Gradual disease progression during long-term follow up of patients with late-onset Pompe disease 2007 ·Neuromuscular Disorders ·(unknown),M.L.C. Hagemans,Arnold Reuser,Wim C.J. Hop,Ans van der Ploeg,P. van Doorn,(unknown)	1
18	M.P.5.08 Physician reported outcomes of enzyme replacement therapy in older, severely affected patients with Pompe disease 2007 ·Neuromuscular Disorders ·Ans van der Ploeg,Deborah Marsden	1
19	M.P.5.01 Two years follow-up of enzyme therapy in five children with Pompe disease 2007 ·Neuromuscular Disorders ·(unknown),(unknown),M.L.C. Hagemans,W.F.M. Arts,J. Jaeken,(unknown),A. J. J. Reuser,Ans van der Ploeg	0
20	Isolation and Characterisation of a Recombinant, Precursor form of Lysosomal Acid α‐Glucosidase 1995 ·European Journal of Biochemistry ·Maria Fuller,Ans van der Ploeg,Arnold Reuser,Donald S. Anson,John J. Hopwood	37

About Ans van der Ploeg

Ans van der Ploeg is a scholar working on Rheumatology, Physiology and Psychiatry and Mental health, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (44 papers), Glycogen Storage Diseases and Myoclonus (30 papers) and Child Nutrition and Feeding Issues (15 papers). The work is most often cited by research in Rheumatology (476 citations), Physiology (798 citations) and Epidemiology (460 citations). Ans van der Ploeg has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Arnold Reuser, Priya S. Kishnani, Michael Beck, André Bernards, John C. Boothroyd, George Cross, Sharon L. Coleman, Marian A. Kroos, Nathalie Guffon and Elsa Shapiro. Their work appears in journals such as Cell, Neurology and PEDIATRICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact